                               SEQUENCE LISTING

<110> MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
 
<120> METHODS AND MATERIALS FOR DETECTING C9ORF72 HEXANUCLEOTIDE
      REPEAT EXPANSION POSITIVE FRONTOTEMPORAL LOBAR DEGENERATION OR
      C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION POSITIVE AMYOTROPHIC
      LATERAL SCLEROSIS

<130> 07039-1197WO1

<140>
<141>

<150> 61/756,318
<151> 2013-01-24

<160> 21    

<170> PatentIn version 3.5

<210> 1
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ahx

<220>
<223> C-term amide

<400> 1
Cys Xaa Gly Pro Gly Pro Gly Pro Gly Pro Gly Pro Gly Pro Gly Pro 
1               5                   10                  15      


Gly Pro 
        


<210> 2
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Gly Pro Gly Pro Gly Pro Gly Pro Gly Pro Gly Pro Gly Pro Gly Pro 
1               5                   10                  15      


<210> 3
<211> 6
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
ggggcc                                                                   6


<210> 4
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Pro Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro Pro 
1               5                   10                  15      


Gly Pro Pro Gly Pro Pro Gly Pro 
            20                  


<210> 5
<211> 6
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
ggcccc                                                                   6


<210> 6
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ahx

<220>
<223> C-term amide

<400> 6
Cys Xaa Gly Ala Gly Ala Gly Ala Gly Ala Gly Ala Gly Ala Gly Ala 
1               5                   10                  15      


Gly Ala 
        


<210> 7
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ahx

<220>
<223> C-term amide

<400> 7
Cys Xaa Gly Arg Gly Arg Gly Arg Gly Arg Gly Arg Gly Arg Gly Arg 
1               5                   10                  15      


Gly Arg 
        


<210> 8
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Gly Ala Gly Ala Gly Ala Gly Ala Gly Ala Gly Ala Gly Ala Gly Ala 
1               5                   10                  15      


<210> 9
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Gly Arg Gly Arg Gly Arg Gly Arg Gly Arg Gly Arg Gly Arg Gly Arg 
1               5                   10                  15      


<210> 10
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Gly Lys Gly Lys Gly Lys Gly Lys Gly Lys Gly Lys Gly Lys Gly Lys 
1               5                   10                  15      


<210> 11
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid except Gly, Ala, Pro, Arg, Cys, 
      Val or Lys

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any amino acid except Gly, Ala, Pro, Arg, Cys, 
      Val or Lys

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid except Gly, Ala, Pro, Arg, Cys, 
      Val or Lys

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid except Gly, Ala, Pro, Arg, Cys, 
      Val or Lys

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any amino acid except Gly, Ala, Pro, Arg, Cys, 
      Val or Lys

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any amino acid except Gly, Ala, Pro, Arg, Cys, 
      Val or Lys

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Any amino acid except Gly, Ala, Pro, Arg, Cys, 
      Val or Lys

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any amino acid except Gly, Ala, Pro, Arg, Cys, 
      Val or Lys

<400> 11
Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa Gly Xaa 
1               5                   10                  15      


<210> 12
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ahx

<220>
<223> C-term amide

<400> 12
Cys Xaa Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Ala 
1               5                   10                  15      


Pro Ala 
        


<210> 13
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Ahx

<220>
<223> C-term amide

<400> 13
Cys Xaa Pro Arg Pro Arg Pro Arg Pro Arg Pro Arg Pro Arg Pro Arg 
1               5                   10                  15      


Pro Arg 
        


<210> 14
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Gly Arg Gly Arg Gly Arg Gly 
1               5           


<210> 15
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Gly Pro Gly Pro Gly Pro Gly 
1               5           


<210> 16
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Gly Ala Gly Ala Gly Ala Gly 
1               5           


<210> 17
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 17
ggggccgggg ccggggccgg ggcc                                              24


<210> 18
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 18
ggccccggcc ccggccccgg cccc                                              24


<210> 19
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Pro Gly Pro Gly Pro Gly Pro 
1               5           


<210> 20
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Pro Arg Pro Arg Pro Arg Pro 
1               5           


<210> 21
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Ala Pro Ala Pro Ala Pro Ala 
1               5           


